Wertpapiername | Anteil |
---|---|
AstraZeneca PLC | 2,60 % |
Novartis AG | 2,50 % |
TotalEnergies SE | 2,40 % |
Chubb Ltd | 2,40 % |
Johnson & Johnson | 2,30 % |
Microsoft Corp | 2,30 % |
Duke Energy Corp | 2,00 % |
Cisco Systems Inc | 2,00 % |
Merck & Co | 2,00 % |
Accenture PLC | 1,90 % |
Summe: | 22,40 % |
The Fund seeks long-term total returns, in excess of the MSCI All Country World Index (the 'Index') primarily through investment in equity and equity-related securities of companies worldwide. The Investment Manager will actively manage the Fund, using fundamental bottom-up analysis to identify resilient, less volatile, dividend-paying companies that the Investment Manager believes have been discounted for transitory reasons. The Fund is generally unconstrained by market capitalisation and sector but is expected to have a bias towards large-capitalisation companies and may invest in both developed and emerging markets.. The Fund's exposure to emerging markets shall not exceed 15% of the net asset value. The Fund will invest in shares and other securities with equity characteristics such as depositary receipts. The Fund may invest either directly or via derivatives.